These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28240674)

  • 1. A second wind for the cholinergic system in Alzheimer's therapy.
    Douchamps V; Mathis C
    Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):112-123. PubMed ID: 28240674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.
    Auld DS; Kornecook TJ; Bastianetto S; Quirion R
    Prog Neurobiol; 2002 Oct; 68(3):209-45. PubMed ID: 12450488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development.
    Terry AV; Buccafusco JJ
    J Pharmacol Exp Ther; 2003 Sep; 306(3):821-7. PubMed ID: 12805474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease?
    Martorana A; Esposito Z; Koch G
    CNS Neurosci Ther; 2010 Aug; 16(4):235-45. PubMed ID: 20560995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.
    Hampel H; Mesulam MM; Cuello AC; Farlow MR; Giacobini E; Grossberg GT; Khachaturian AS; Vergallo A; Cavedo E; Snyder PJ; Khachaturian ZS
    Brain; 2018 Jul; 141(7):1917-1933. PubMed ID: 29850777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET studies and cholinergic therapy in Alzheimer's disease.
    Nordberg A
    Rev Neurol (Paris); 1999; 155 Suppl 4():S53-63. PubMed ID: 10637939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems.
    Lawrence AD; Sahakian BJ
    Neurochem Res; 1998 May; 23(5):787-94. PubMed ID: 9566619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergically mediated augmentation of cerebral perfusion in Alzheimer's disease and related cognitive disorders: the cholinergic-vascular hypothesis.
    Claassen JA; Jansen RW
    J Gerontol A Biol Sci Med Sci; 2006 Mar; 61(3):267-71. PubMed ID: 16567376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?
    Amenta F; Parnetti L; Gallai V; Wallin A
    Mech Ageing Dev; 2001 Nov; 122(16):2025-40. PubMed ID: 11589920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of Alzheimer's disease].
    Bombois S; Lebert F; Vellas B; Pasquier F
    Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Old and new acetylcholinesterase inhibitors for Alzheimer's disease.
    Galimberti D; Scarpini E
    Expert Opin Investig Drugs; 2016 Oct; 25(10):1181-7. PubMed ID: 27459153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical pathology and treatment strategies in Alzheimer's disease: emphasis on the cholinergic system.
    Winblad B; Messamore E; O'Neill C; Cowburn R
    Acta Neurol Scand Suppl; 1993; 149():4-6. PubMed ID: 8128837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy for Neurocognitive Disorders Based on the Hypothesis of Endogenous Appearance of Anticholinergic Activity.
    Hosoi M; Hori K; Konishi K; Tani M; Tomioka H; Kitajima Y; Akashi N; Inamoto A; Kurosawa K; Yuda H; Hanashi T; Ouchi H; Hachisu M
    Neurodegener Dis; 2015; 15(3):157-61. PubMed ID: 26138493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic therapy for neuropsychiatric symptoms in neurologic disorders.
    Kaufer DI
    Curr Psychiatry Rep; 1999 Oct; 1(1):78-84. PubMed ID: 11122908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cholinergic pathology in Alzheimer's disease--discrepancies between clinical experience and pathophysiological findings.
    Frölich L
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1003-13. PubMed ID: 12111437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement.
    Brousseau G; Rourke BP; Burke B
    Exp Clin Psychopharmacol; 2007 Dec; 15(6):546-54. PubMed ID: 18179307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical basis for symptomatic treatment of Alzheimer's disease.
    Francis PT; Ramírez MJ; Lai MK
    Neuropharmacology; 2010; 59(4-5):221-9. PubMed ID: 20156462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurotransmitters in Alzheimer's disease].
    Manzano-Palomo S; De la Morena-Vicente MA; Barquero MS
    Rev Neurol; 2006 Mar 16-31; 42(6):350-3. PubMed ID: 16575771
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.